Tags

Type your tag names separated by a space and hit enter

Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Morb Mortal Wkly Rep. 2007 Oct 19; 56(41):1080-4.MM

Abstract

In 1995, highly effective inactivated hepatitis A vaccines were first licensed in the United States for preexposure prophylaxis against hepatitis A virus (HAV) among persons aged > or =2 years. In 2005, vaccine manufacturers received Food and Drug Administration approval for use of the vaccines in children aged 12-23 months.

Pub Type(s)

Journal Article
Practice Guideline

Language

eng

PubMed ID

17947967

Citation

Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). "Update: Prevention of Hepatitis a After Exposure to Hepatitis a Virus and in International Travelers. Updated Recommendations of the Advisory Committee On Immunization Practices (ACIP)." MMWR. Morbidity and Mortality Weekly Report, vol. 56, no. 41, 2007, pp. 1080-4.
Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007;56(41):1080-4.
Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). (2007). Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Morbidity and Mortality Weekly Report, 56(41), 1080-4.
Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Update: Prevention of Hepatitis a After Exposure to Hepatitis a Virus and in International Travelers. Updated Recommendations of the Advisory Committee On Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007 Oct 19;56(41):1080-4. PubMed PMID: 17947967.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Update: Prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). A1 - ,, PY - 2007/10/20/pubmed PY - 2007/10/24/medline PY - 2007/10/20/entrez SP - 1080 EP - 4 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb Mortal Wkly Rep VL - 56 IS - 41 N2 - In 1995, highly effective inactivated hepatitis A vaccines were first licensed in the United States for preexposure prophylaxis against hepatitis A virus (HAV) among persons aged > or =2 years. In 2005, vaccine manufacturers received Food and Drug Administration approval for use of the vaccines in children aged 12-23 months. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/17947967/Update:_Prevention_of_hepatitis_A_after_exposure_to_hepatitis_A_virus_and_in_international_travelers__Updated_recommendations_of_the_Advisory_Committee_on_Immunization_Practices__ACIP__ L2 - https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5641a3.htm DB - PRIME DP - Unbound Medicine ER -